RELEASE: United Imaging Intelligence presented next generation radiology solutions at ECR 2024

(Information sent by the signatory company).

RELEASE: United Imaging Intelligence presented next generation radiology solutions at ECR 2024

(Information sent by the signatory company)

VIENNA, March 1, 2024 /PRNewswire/ -- At the European Congress of Radiology (ECR) 2024 in Vienna, United Imaging Intelligence (UII), a subsidiary of United Imaging Group, proudly presented its latest advances in medical AI technology . Recognized for its AI-powered healthcare applications, UII's presentation at ECR 2024 marked a significant leap towards "Next Generation Radiology", showcasing intelligent healthcare solutions in line with the forward-looking theme of the congress.

Pioneering AI Applications for Large Medical Imaging Models and Surgical Planning

Amid the rapid transformation of the medical technology landscape driven by core models, UII adopts these crucial frameworks to enhance “next-generation radiology.” A vital aspect of this advancement is AI research in medical imaging. At ECR 2024, UII introduced uAI SAT, an innovative AI-based annotation tool hosted on its biomedical research platform. Using a large medical image model, uAI SAT enhances intelligent interactive segmentation, significantly shortening annotation times from hours to minutes and contributing to the advancement of scientific research.

The uAI Pioneer Portal, UII's flagship exhibition, captivated visitors with its advanced 3D preoperative planning applications designed for thoracic, hepatobiliary and urological surgeries. The standout feature of the portal is its one-click functionality for 3D reconstruction of injuries and organs at the diagnostic level. Coupled with a gesture-controlled 3D monitor, this technology allows users to interact with virtual reality and manipulate detailed models using hand gestures, eliminating the need for 3D glasses or headsets. Provides clinicians with an immersive and intuitive visualization of the patient's preoperative plan and intraoperative anatomy.

Advancing comprehensive, full-spectrum innovations for clinical diagnostics

The UII exhibition went beyond showcasing technological innovations. It also presented a collection of clinical solutions for neurology, cardiology, thorax and oncology. Among the many advancements, the CE Mark certification obtained for specific AI applications within UII's thoracic solutions, including uAI Discovery Pulmonary Nodules, uAI Discover Pneumonia, and uAI Discover Fracture, underscored UII's commitment to care innovation. Of the health. Using a single chest CT scan, the Thoracic Solution offers evaluation of more than 10 prevalent thoracic conditions, effectively minimizing radiation exposure and patient wait time.

In neurology, UII's AI solutions cover the entire stroke management process, from intensive care to research. Recognizing the critical nature of timely intervention in stroke management, UII has developed CT-based AI models that enable rapid and accurate identification of strokes, thereby simplifying the treatment workflow. Significant progress has also been made in the development of MRI-based brain disease diagnostic models, which improve management strategies and contribute to advances in neuroscience research.

According to the WHO, cardiovascular diseases are one of the leading causes of death worldwide, claiming an estimated 17.9 million lives each year. UII's comprehensive cardiac imaging solutions have become indispensable. By integrating CT and MRI evaluations, UII cardiovascular solutions provide detailed analyzes of anatomical, functional and tissue characteristics, optimizing image post-processing and significantly reducing the time required for diagnosis.

Finally, UII's dedication to oncology is also demonstrated through its comprehensive suite of applications spanning imaging, detection, diagnosis and treatment for a variety of cancers, including lung cancer, prostate cancer, breast cancer and metastatic diseases.

UII firmly believes that medical AI represents a critical catalyst driving radiology into a new era of transformation. Having deployed its innovative products in more than 3,000 medical institutions worldwide and formed research and product collaborations in Europe, UII remains steadfast in its mission to further expand development and partnerships across the region, striving for making the benefits of medical AI universally accessible.

(Notes: The products and features mentioned in this document may not be commercially available in all countries. Future availability cannot be guaranteed.)

Photo -

Photo -

View original content: